This study is to investigate the molecular mechanism of radiation-enhanced cell invasiveness of hepatocellular carcinoma (HCC) correlating with clinical patients undergoing radiotherapy and subsequently developing metastasis. Three HCC cell lines (HepG2, Hep3B and Huh7) and normal hepatocyte cell line (CL-48) were irradiated with different doses. The effect of radiation on cell invasiveness was determined using the Boyden chamber assay. Radiation-enhanced invasion capability was evident in HCC cells but not in normal hepatocytes. Invasion was observed in gelatin-coated but not fibronectin-coated or type I collagen-coated membranes. Radiation upregulated matrix metalloproteinase-9 (MMP-9) mRNA level, MMP-9 protein level and MMP-9 activity. MMP-9 antisense oligonucleotides inhibited radiation-induced MMP-9 expression and thereby significantly inhibited radiationinduced HCC invasion. Furthermore, phosphatidylinositol 3-kinase (PI3K)/Akt chemical inhibitors LY294002 and wortmannin suppressed radiation-induced MMP-9 mRNA expression. Transient transfection with dominantnegative Akt plasmid also showed that the PI3K/Aktsignaling pathway was involved in this radiation-induced MMP-9 expression. Moreover, nuclear factor-jB (NFjB) decoy oligodeoxynucleotide suppressed radiation enhanced MMP-9 promoter activity completely. PI3K/ Akt chemical inhibitors inhibited radiation-induced NFjB-driven luciferase promoter activity. Taken together, our results indicated that sublethal dose of radiation could enhance HCC cell invasiveness by MMP-9 expression through the PI3K/Akt/NF-jB signal transduction pathway.
Introduction
Radiation has been a cancer therapy for more than a hundred years. Nowadays, more than 50-60% of cancer patients need radiotherapy as a part of their cancer treatment. The rationale of radiotherapy in cancer treatment is based on the observation that radiation can inhibit cell proliferation or induce apoptotic cell death in vitro, and suppress tumor growth in vivo (Fu and Phillips, 1991) . Besides the therapeutic effect, recent evidence has shown that irradiation may promote malignant behaviors of cancer cells both in vitro (Wild-Bode et al., 2001 ) and in vivo (Camphausen et al., 2001) by activating several pathways involved in tumor invasiveness and metastasis (Onoda et al., 1992; Akimoto et al., 1998; Wang et al., 2000) .
The metastasis of cancer causes the majority of human cancer deaths. It remains the greatest barrier to cancer cure. Cancer cell invasion and metastasis are complicated processes involving several classes of proteins (e.g., calcium-dependent cadherins, integrins, extracellular proteases, angiogenetic factors and lymphangiogenesis factors). Among these factors, tumorassociated matrix metalloproteinases (MMPs) have been important components of this process because they degrade extracellular matrix proteins. The expression and activity of MMPs increase in almost all human cancer types and are associated with advanced tumor stage and poor survival. Increased plasma level of MMP-9 has been found in lung cancer and breast cancer during radiotherapy (Susskind et al., 2003) . Moreover, an MMP inhibitor has been shown to block radiationinduced invasiveness of human pancreatic cancer cells (Qian et al., 2002) .
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Radiotherapy has been integrated into one of the treatment modalities (Aguayo and Patt, 2001) . Several clinical studies showed that a significant proportion of HCC patients undergoing radiotherapy subsequently develop intrahepatic and extrahepatic metastasis (Cheng et al., 2001; Liang et al., 2005) . This development was associated with a detrimental outcome. In this study, we were mainly interested in clarifying the molecular mechanism of radiation-induced HCC invasiveness and metastatic capability. We exposed HCC cell lines to sublethal doses of radiation and showed that radiation enhanced invasion capability. The capability was dependent on increased MMP-9 activity mediated mainly through the phosphatidylinositol 3-kinase (PI3K)/Akt/nuclear factor-kB (NF-kB) signaling transduction pathway.
Results

Radiation enhances invasiveness of HCC cell lines
Three human HCC cell lines, HepG2, Huh-7 and Hep3B, and the normal hepatocyte cell line, CL-48, were plated in Boyden chambers with Matrigel-coated membranes, mimicking the basement membrane which serves as a barrier to invasion. The cells were irradiated with different doses from 5 to 10 Gy. After 16 h, the cells were fixed, stained with crystal violet, and counted. The result shown in Figure 1a indicated that 7.5 Gy of radiation significantly enhanced cell invasiveness. The effect was evident for all three HCC cell lines but not the normal hepatocyte cell line. We further confirmed the invasiveness of HCC cells and normal hepatocyte cell line CL-48 by an intravasation chorioallantoic membrane (CAM) assay. All the cells were irradiated with 7.5 Gy before being seeded on the upper CAM. After 48 h, cells invading the lower CAM were quantified using polymerase chain reaction (PCR) of the human genome-specific Alu sequence. The result shown in Figure 1b indicated that radiation enhanced the invasiveness of HCC cells. The radiation-enhanced invasiveness in the CAM assay was evident in all three HCC cells but not in normal hepatocyte cell line.
Radiation dose-response of HCC cells and normal hepatocytes The Trypan blue exclusion assay showed reduced growth rate of all cell lines irradiated with 7.5 Gy (Figure 2a ). However, cell death was rare at this dose either at 24 or 48 h. Cell cycle distribution of HepG2 cells at 24 h by propidium iodide staining and flow cytometry ( Figure 2b ) showed no obvious sub G1 cell death peak. The distribution of G1 and G2/M was shifted with G2/M arrest. Results of a colony formation assay confirmed the long-term effect of radiation on HepG2 and Hep3B cells (Figure 2c ). The morphology and quantification data demonstrated that 7.5 Gy still inhibited HCC cell growth.
Radiation-induced HCC invasiveness depends on cell matrix component specificity Extracellular matrix, which acts as a tissue barrier, has different components such as gelatin, collagen, fibronectin, etc. The invasiveness of cancer cells is frequently associated with their ability to degrade certain of these matrix materials. We were interested in identifying the matrix composition most vulnerable to radiation-enhanced invasion by tumor cells. Different HCC cells were seeded on Boyden chamber membranes coated with different cell matrix materials, including Matrigel, gelatin, fibronectin, and type I collagen, and irradiated with 7.5 Gy (Figure 3a) . After 16 h, the invaded cells were fixed and stained with crystal violet, and highpower fields were digitally photographed. Figure 3b showed that the radiation-enhanced HepG2, Huh7 and Hep3B cells could all invade through gelatin. The results imply that cell invasiveness correlates with specific enzyme activities and that these are critical in radiation-enhanced HCC cell invasiveness.
MMP-9 expression is involved in radiation-enhanced HCC cell invasiveness The cancer cell invasiveness has been linked to increased expression of MMP proteins. Several MMP family proteins, including MMP-1, -2, -3 and -9, are overexpressed and associated with poor prognosis in HCC patients. Reverse transcriptase (RT)-PCR expression patterns of MMP-1, -2, -3 and -9 mRNA in HepG2 cells (Figure 4a ) showed that MMP-1, -2 and -3 mRNA were downregulated, but MMP-9 mRNA was upregulated, with increasing radiation dose. However, 10 Gy did not increase MMP-9 mRNA expression, which might be attributed to severe damage of cell protein at this dose. were seeded in Matrigel-coated Boyden chambers. Cells were irradiated with different doses as indicated. After 16 h, the number of cells invading the membranes was counted as mean7s.d. from three independent experiments. Student's t-test was used to evaluate the difference between groups. *Po0.05 (b) HepG2, Huh-7, Hep3B cells and normal hepatocyte cell line CL-48 were irradiated with 7.5 Gy and the cell invasion was determined by an intravasation PCR-based assay. The human cancer cells in the lower chorioallantoic membrane (CAM) were determined using PCR of the human genome-specific Alu sequence and the specific Alu primer. Data presented were fold of radiation group compared with sham group7s.d. from five independent experiments. Student's -t-test was used to evaluate the difference between groups. *Po0.05.
The protein level of cytosolic MMP-9 (Figure 4b ) as well as in the cell culture supernatant and its protein activity by zymography (Figure 4c ) confirmed this expression pattern. The protein level of MMP-9 increased significantly in three HCC cell lines irradiated with 7.5 Gy, but not in normal hepatocytes (Figure 4d ).
The role of MMP-9 in radiation-enhanced HepG2 cell invasiveness was further tested using an antisense strategy to inhibit MMP-9 gene expression. HepG2 cells were treated with antisense (As) MMP-9 oligonucleotide or sense (S) oligonucleotide before being irradiated and then assayed for Matrigel invasion capability. Treatment with As MMP-9 oligonucleotide significantly inhibited the radiation-enhanced HepG2 cell invasiveness. The effect of As MMP-9 oligonucleotide was confirmed by Western blotting using MMP-9-specific antibody (Figure 4e ). Similar inhibitory effect of As MMP-9 oligonucleotide on radiation-enhanced invasiveness was shown in the in vivo CAM assay (Figure 4f ). HepG2 cells, with transiently transfected MMP-9, showed the enhanced invasiveness in the in vitro Boyden chamber assay (Figure 4g ). The activity of MMP-9 in cell culture was clarified by gelatin zymography assay. Therefore, the ability of radiationenhanced HCC cells to invade Matrigel-coated membranes is dependent on the induction of MMP-9 expression.
Radiation-activated PI3K/Akt signal transduction pathway is involved in radiation-enhanced MMP-9 expression Radiation has been found to activate several intracellular signaling pathway mediators, such as mitogenactivated protein kinase (MAPK) and PI3K. We investigated the effect of radiation on the downstream activation of the MAPK and PI3K pathways by detecting phosphorylated p38, extracellular signal- regulated kinase (ERK), c-Jun NH 2 -terminal kinase (JNK) and Akt. Furthermore, to inhibit phosphorylation of these proteins, we used SB203580 for p38, PD98059 for MAPK/ERK, LY294002 for PI3K/Akt and SP600125 for JNK. Radiation (7.5 Gy) was found to promote p38, ERK, JNK, and Akt phosphorylation in HepG2 cells (Figure 5a ). By pretreating with different chemical inhibitors and assaying MMP-9 protein levels in cell culture supernatants (by EIA), we showed that radiation-induced MMP-9 protein expression in HepG2 cells could be inhibited by the PI3K/Akt-specific inhibitor LY294002 (Figure 5b ). We further examined the PI3K/Akt-signaling pathway by performing a 72-h transient transfection of HepG2 cells with dominantnegative (dn)Akt to block the phosphorylation of wild-type cytosolic Akt. The transfection efficiency (calculated from green fluorescent protein expression levels) in HepG2 cells using our protocol was about 21%. The ratios of phosphorylated-Akt/nonphosphorylated Akt in dnAkt transfectants and vector controls (pcDNA-3) to that in sham controls measured by densitometry were 1.5 and 1.9, respectively. The phosphorylated Akt/nonphosphorylated Akt inhibition ratio of the dnAkt transfectants was 21% less than the ratio in pcDNA-3 (vector) controls. In addition, the ratios of MMP-9 in dnAkt transfectants and vector controls to that in sham controls measured by densitometry were 1.3 and 1.7, respectively. The MMP-9 inhibition ratio of the dnAkt transfectants was 23% less than that of the pcDNA-3 group. The transient transfected-dnAkt cell line exhibited a marked reduction in radiation-induced MMP-9 expression when compared with the vector control ( Figure 5c ). The above findings indicate that PI3K and its downstream Akt are activated by radiation and are critically involved in radiation-induced MMP-9 expression.
PI3K/Akt signal transduction-mediated NF-kB activation is involved in radiation-induced MMP-9 expression The regulation of the radiation effect on MMP-9 was investigated at the transcriptional level using a luciferase reporter plasmid containing a 0.7-kb segment at the 5 0 -flanking region of the human MMP-9 promoter region. There were NF-kB and AP-1-binding sites on this MMP-9 promoter region. After transfection with MMP-9 promoter luciferase plasmid for 24 h, HepG2 cells were treated 1 h prior to irradiation (7.5 Gy) with a cis element decoy agonist NF-kB-binding site (decoy NF-kB), AP-1-binding site (decoy AP-1), or scrambled decoy (SD) to block the transcriptional factor binding site. After 6 h, the MMP-9 promoter luciferase activity was determined (Figure 6a ). Radiation did induce MMP-9 promoter luciferase activity. However, this induction could be significantly suppressed by decoy NF-kB but not by decoy AP-1 or SD.
Our next step was to test whether PI3K/Akt signaling is involved in radiation-induced NF-kB activity, using a NF-kB-binding site-driven luciferase activity assay. After transfection with NF-kB-binding site-driven luciferase plasmid for 24 h, HepG2 and Hep3B cells were treated for 1 h prior to irradiation (7.5 Gy) with PI3K/ Akt chemical inhibitors, LY294002 and wortmannin or dimethyl sulphoxide (DMSO) solvent control (vehicle). After 1 h, the NF-kB promoter luciferase activity was determined as described in Materials and methods, and the result is shown in Figure 6b . The radiation-induced NF-kB promoter luciferase activity was significantly suppressed by both PI3K/Akt chemical inhibitors but not by the DMSO solvent control.
The PI3K/Akt-signaling pathway involved in radiation-induced NF-kB activity was further examined by detecting NF-kB nuclear translocation. HepG2 cells were treated 1 h prior to irradiation (7.5 Gy) with PI3K/ Akt chemical inhibitors LY294002. After 1 h, the cytosol and nuclear proteins were isolated and assayed for NF-kB p65 by Western blotting with specific antibody (Figure 6c ). The radiation-induced NF-kB p65 nuclear translocation was inhibited by LY294002 and thereby showed PI3K/Akt signaling was involved in this process.
Finally, the involvement of PI3K/Akt signaling and NF-kB in radiation-induced MMP-9 expression was The protein levels of MMP-9 and MMP-2 were determined using specific antibodies and Western blotting. Tubulin was used as a loading control. (c) The protein level of MMP-9 in cell culture supernatant was determined using EIA. Enzyme activity of MMP-9 was determined using zymography. (d) All three HCC cell lines and normal hepatocyte cell line CL-48 were irradiated with 7.5 Gy, with the protein level of MMP-9 in cell culture supernatant determined. The non-irradiated cells were served as the control. Folds of MMP-9 protein expression were compared as mean7s.d. from three independent experiments. (e) HepG2 cells were treated with antisense (As) MMP-9 oligodeoxynucleotides (ODNs) or sense (S) ODNs before radiation. The inhibition with AsODNs was confirmed by Western blotting, and the effect on radiation-enhanced cell invasion was determined using the Boyden chamber assay. (f) The inhibitory effect of MMP-9 AsODN on irradiated HepG2 cells was determined in the CAM assay. Data presented were the ratio of radiation group and sham group7s.d. from three independent experiments, with five eggs in each group. (g) HepG2 cells were transiently transfected with MMP-9 expression vector for the in vitro invasion test. In the upper panel, the MMP-9 activity was shown by the gelatin zymography assay with the digested area quantified by densitometer. Data presented were the number of invaded cells as mean7s.d. from three independent experiments. Student's -t-test was used to evaluate the difference between groups. *Po0.05.
confirmed by zymography of MMP-9 enzyme activity. HepG2 cells were treated for 1 h prior to irradiation (7.5 Gy) with the PI3K/Akt chemical inhibitor wortmannin, or the NF-kB chemical inhibitor BAY11-7082. After 24 h, the cell culture supernatant was collected for analysis by zymography (Figure 6d ). Both wortmannin and BAY11-7082 reduced radiation-induced MMP-9 enzyme activity and protein level. Taken together, our results demonstrated that the invasiveness of HCC cells enhanced by a sublethal dose of radiation (7.5 Gy) was mainly through the PI3K/Akt/NF-kBsignaling pathway that regulates MMP-9 expression (Figure 7 ).
Discussion
Our data demonstrated that a sublethal dose of radiation enhanced the invasiveness of HCC cells but not normal hepatocytes. These findings are compatible with our clinical observation of more frequent metastasis in HCC patients undergoing fractionated radiotherapy (Cheng et al., 2001; Liang et al., 2005) . Given that intrahepatic and extrahepatic metastasis reduces survival in HCC patients, the possibility of metastasis due to radiotherapy deserves serious attention in clinical practice. Hepatic reserve is used as the main prognostic indicator in HCC patients, and the presence of metastasis is likely to confound prediction based on this indicator. Since radiotherapy is often part of the treatment of HCC, delineation of the molecular mechanism of this radiation-induced biological effect is urgently needed.
Migration and invasion are the important prerequisites of cancer progression and metastasis. Several studies indicate that radiation promotes invasiveness and metastasis of cancer cells. Wild-Bode et al. (2001) showed the enhanced migration and invasiveness of human malignant glioma cells exposed to sublethal irradiation. Hegedus et al. (2004) demonstrated increased migration of glioblastoma cells irradiated with 2-10 Gy. They found that doses of more than 10 Gy or the addition of chemotherapeutic drugs could impair migration. This finding implies the therapeutic effect may be improved by combining chemotherapy with sublethal doses of radiation. The fractionated dose of clinical radiotherapy was close to the sublethal dose in these in vitro studies. Although migration, invasion or even metastasis due to fractionated radiation might only occur in certain specific cancer types, cautious clinical observation and verification is warranted. Enzymatic degradation of extracellular matrix is one of the crucial steps in cancer invasion and metastasis. In human HCC, MMP-1, -2, -3 and -9 have been found to correlate with malignant grade and metastasis (Kuyvenhoven et al., 2003; Woo et al., 2003; Sugioka et al., 2004) . Our data showed that the enhanced invasiveness is specific for gelatin, the substrate of MMP-9 (gelatinase B). MMP-9 is synthesized by cancer cells and plays an important role in tumor cell invasion, metastasis and angiogenesis in HCC (Murawaki et al., 2000) . Angiogenesis triggered by tissue ischemia also requires MMP-9 to restore capillary branching (Murawaki et al., 2000) . Radiation markedly increased the level of MMP-9 and its mRNA expression in the cocultures of glioblastoma cells and retinal endothelial cells (Nirmala et al., 2000) . On the other hand, the inhibition of radiation-enhanced MMP-9 protein expression with As oligonucleotides significantly suppressed radiation-induced invasion (London et al., 2003) . Similarly in this study, MMP-9 was upregulated by radiation, and the As strategy was able to inhibit invasiveness. Therefore, MMP-9 may be the radiation-responsive mediator, and its degradation of extracellular matrix may cause subsequent cancer invasion and metastasis.
Radiation exposure is a kind of stress, and may induce the compensatory activations of multiple intracellular signaling pathway mediators, such as PI3K, MAPK, JNK and NF-kB (Criswell et al., 2003; Dent et al., 2003) . Our data showed that radiation could activate PI3K/Akt, MAPK/ERK, JNK and p38, but the inhibitor of PI3K/Akt was the only one to regulate MMP-9. Ruhul Amin et al. (2003) reported PI3K-Akt was one of the signaling pathways to induce MMP-9 secretion. Recently, hepatitis B viral HBx was shown to induce MMP-9 gene expression through the activation of the ERK and PI3K/Akt pathways (Chung et al., 2004) . More importantly, angiogenesis plays an essential role in tumor growth and metastasis. Vascular endothelial cell proliferation and migration Figure 6 PI3K/Akt signal transduction-mediated NF-kB activation is involved in radiation-induced MMP-9 regulation in HepG2 cells. (a) HepG2 cells were transfected with MMP-9 promoter-driven luciferase plasmid for 24 h, and were treated for 1 h before irradiation (7.5 Gy) with NF-kBODN and AP-1ODN. After 6 h, the promoter luciferase activities were detected using a luminometer. Data are presented as mean folds7s.d. from three independent experiments. (b) HepG2 cells were transfected with NF-kB promoterdriven luciferase plasmid for 24 h, and were treated for 30 min before irradiation (7.5 Gy) with chemical inhibitors. After 6 h, the promoter luciferase activities were detected using a luminometer. (c) The protein levels of cytosolic NF-kB and nuclear NF-kB were determined using specific antibodies and Western blotting. (d) The effects of PI3K/Akt and NF-kB on radiation-enhanced MMP-9 expression were confirmed using zymography. represents critical steps in angiogenesis. Steinle et al. (2002) proposed the signaling of endothelial cell proliferation by a PI3K/Akt/endothelial nitric-oxide synthase/protein kinase G/MAPK cascade. Nakashio et al. (2002) found that PI3K-Akt was downregulated during topotecan-mediated inhibition of endothelial cell angiogenesis. Yao et al. (2004) similarly demonstrated that minocycline exerted its inhibitory effect on angiogenesis by suppressing MMP-9 mRNA transcription and downregulating ERK1/2 and PI3K/ Akt signal pathways. O-charoenrat et al. (2004) showed that beta-cellulin induced MMP-9 production and invasion in head-and-neck squamous carcinoma cells through activation of EGFR, MAPK and PI3K/Akt. In ovarian cancer cells, Thant et al. (2000) suggested both MEK1-MAPK and PI3K-Akt were required for the fibronectin-dependent activation of MMP-9 secretion and the resultant cell invasiveness. These studies and our current data indicate that MMP-9 is associated with invasion capability mediated at least in part by PI3K-Akt.
There exist multiple transcription factor consensus binding motifs in the MMP-9 promoter, including NFkB, SP-1, Ets, AP-1, and a retinoblastoma-binding element (Sato and Seiki, 1993) . To date, three transcription factors (p53, NF-kB and the SP1-related retinoblastoma control proteins) appear to be responsive to the physiological radiation dose, the dose wherein cells survive or recover (Moon et al., 2004) . In this study, NF-kB but not AP-1, modulated the radiation-induced MMP-9 activity in HepG2 cells on zymography. Wei et al. (2005) also reported that NF-kB rather than AP-1 was involved in the radiation response of cervical cancer cell line Caski. We further demonstrated PI3K/Akt was involved in the radiation-induced NF-kB activity in HepG2 cells. This pathway also exists in the other cell models. Huang et al. (2005) showed the inhibitory effect of carnosol on melanoma cell migration and invasion occurred mainly as a result of reduced MMP-9 expression, which was mediated through suppressing the ERK1/2, Akt, p38 and JNK pathways and inhibiting NF-kB-and AP-1-binding activities. Moreover, Agarwal et al. (2005) found that PI3K/Akt/IkB pathway positively regulated NF-kB and b-catenin in colorectal cancer cells, and using array analysis, that most of the PI3K/Akt/IkB genes are involved in tumor angiogenesis and metastasis.
We conclude that a sublethal dose of radiation enhances invasiveness of HCC cells, mainly through MMP-9 expression mediated by PI3K/Akt/ NF-kB signal transduction pathway. Therapeutic improvement is based not only on eradicating local disease, but on controlling systemic dissemination of cancer cells. The clinical implication of this study is the critical need to suppress processes such as radiation-enhanced invasiveness of HCC cells. With the clarification of signal transduction mediators involved in this process, it may be possible to develop specific inhibitors to modulate unwanted metastatic signaling while retaining the therapeutic benefit of radiation for treating localized disease.
Materials and methods
HCC cell lines
The human HCC cell lines, HepG2, Huh7, Hep3B and normal hepatocyte CL-48 were obtained from the American Type Culture Collection (Manassas, VA, USA). Cell cultures were maintained in Dulbecco's-modified Eagle's medium (DMEM) supplemented with nonessential amino acids, L-glutamine, a twofold vitamin solution (Life Technologies Inc., Grand Island, NY, USA), sodium pyruvate, 10% fetal bovine serum, penicillin, and streptomycin (Flow Labs, Rockville, MD, USA). Cells were cultured at 371C in a humidified atmosphere of 5% CO 2 and 95% air.
Radiation and chemical reagents
The flask was irradiated with different doses of radiation (0-10 Gy), using a Cobalt-60 unit. Source-skin-distance was set at 80 cm to the bottom of the flask. The dose rate was 1 Gy/ min. Chemical inhibitors, SB203580, PD98059, LY294002, SP600125 and wortmannin were obtained from Sigma (St Louis, MO, USA). BAY 11-7082 was obtained from Calbiochem (San Diego, CA, USA).
Boyden chamber invasion assay Invasion chambers were prepared by coating the membranes (8 mm pore) of 24-well inserts with 10 mg/ml Matrigel (BD), 0.2 mg/ml gelatin (Sigma), 0.1 mg/ml fibronectin, or 0.2 mg/ml collagen type I (Sigma) and leaving them to set for 1 h at 371C. Cells were detached with 0.25% Tris-ethylenediaminetetraacetic acid. A total of 10 5 cells were added to the upper chamber, suspended in 200 ml of DMEM, with 500 ml of serum-free medium added to the lower chamber. After attaching the cells to the insert, the medium was changed to serum-free medium and was exposed to radiation. After 16 h of incubation, the cells on the upper surface were removed using a cotton bud. The remaining invaded cells were fixed and stained with 0.1% crystal violet for 1 h at room temperature. Finally, invaded cells were counted at Â 200 magnification in 10 different fields of each filter. Experiments were repeated three times.
Intravasation and invasion experiments
To detect the effect of radiation on human HCC cell invasiveness, the quantitative method to detect human alu sequences in chick tissue DNA extracts was modified from Kim et al. (1998) and Zijlstra et al. (2002) . HCC cells were irradiated with 7.5 Gy 1 h before the following experiment. Cells were resuspended (10 6 cells) in 50 ml of phosphatebuffered saline (PBS) with Ca 2 þ and Mg 2 þ , and inoculated onto CAMs of 9-day-old chicken embryos, in which artificial air sacs were created (designated as upper CAMs). Following incubation for 48 h, the lower half of the CAM (designated as the lower CAM) was removed and stored frozen at À801C. Genomic DNA of the frozen tissue was isolated from lower CAMs using the DNA Isolation Kit (QIAGEN Inc., Valencia, CA, USA). To detect human cells in the chick tissues, primers specific for the human alu sequences (sense: 5 0 -ACGCCTGT AATCCCAGCACTT-3 0 ; and As: 5 0 -TCGCCCAGGCTGG AGTGCA-3 0 ) were used to amplify the human alu repeats present in genomic DNA that was extracted from chick tissues. The real-time PCR to amplify and detect alu sequences contained 100 ng of genomic DNA with the same condition as Zijlstra et al. (2002) . A quantitative measure of amplifiable chick DNA was obtained through amplification of the chick glyceraldehydes 3-phospate dehydrogenase (GAPDH) genomic DNA sequence with chGAPDH primers (sense: 5 0 -GAG GAAAGGTCGCCTGGTGGATCG; As: 5 0 -GGTGAGGAC AAGCAGTGAGGAACG) using the same PCR conditions described for alu. Data were collected and analysed with BioRad i-Cycler software. Comparisons of PCR-amplified products were achieved according to the following formula: (radiation group Alu/radiation group chGAPDH)/(sham group Alu/sham group chGAPDH) with five eggs in each group.
Trypan blue exclusion and colony formation assay Cells were cultured in six-well plates for determination of the cell growth curve, and exclusion of Trypan blue (0.12% w/v) was used for determination of cell viability. The effect of radiation on long-term cell viability was assessed by the colony formation assay. Cells (2000/well) were seeded in six-well plates, treated with different doses of radiation, and maintained at 371C in a humidified 10% CO 2 atmosphere. After 7 days, the number of colonies was counted under an inverted phase-contrast microscope at Â 4 magnification and photographed.
Determination of subdiploid DNA content Cells (10 6 /ml) were stimulated as indicated and harvested by centrifugation. Cell cycle analysis was performed by quantifying the DNA content using propidium iodide staining (PBS containing 0.5% Tween 20, 15 mg/ml propidium iodide and 5 mg/ml DNase-free RNase), and was analysed using a Becton Dickinson FACScan and the Cell Quest software (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA).
RT-PCR
Reverse transcription of RNA isolated from cells was performed in a final reaction volume of 20 ml containing 5 mg of total RNA in Moloney murine leukemia virus (MMLV) reverse transcriptase buffer (Promega, Madison, WI, USA). It consisted of 10 mM dithiothreitol, all four deoxynucleoside 5 0 -triphosphates (each at 2.5 mM), 1 mM of (dT) 12-18 primer and 200 U of MMLV reverse transcriptase (Promega). The reaction mixture was incubated at 371C for 2 h, and the reaction was terminated by heating at 701C for 10 min. A portion of the reaction mixture was then amplified by PCR with the following pairs of primers: human (h) MMP-1 (561C, 786 bps): S 5 0 -CGACTCTAGAAACACAAGAGCAAGA-3 0 and As 5 0 -AAGGTTAGCTTACTGTCACACGCTT-3 0 ; hMMP-2 (581C, 580 bps): S 5 0 -GTGCTGAAGGACACACTA AAGAAGA-3 0 and As 5 0 -TTGCCATCCTTCTCAAAGTTG TAGG -3 0 ; hMMP-3 (551C, 515 bps): S 5 0 -AGATGCTGTTG ATTCTGCTGTTGAG-3 0 and As 5 0 -ACAGCATCAAAGGA CAAAGCAGGAT-5 0 ; hMMP-9 (601C, 243 bps): S 5 0 -CACT GTCCACCCCTCAGAGC-3 0 and As 5 0 -GCCACTTGTCG GCGATAAGG-3 0 ; b-actin (601C, 616 bps): S 5 0 -ATCCGCA AAGACCTGTACGC-3 0 and As 5 0 -TGTGTGGACTTGG GAGAGGA-3 0 . Totally, 30 cycles were performed, with each cycle comprising 1 min at 941C, 1 min at 50-601C depending on each gene, and 1.5 min at 721C, with a final extension of 8 min at 721C. All amplifications were conducted within the linear range of the assay, and human b-actin reactions were amplified for 25 cycles. The reaction products were separated on the 2% agarose gel, stained with 1 mg/ml ethidium bromide, and visualized using a UVP GDS-7900 digital imaging system. The results were confirmed by conducting at least three repeated experiments.
Western blot
Total protein was extracted using Mammalian Protein Extraction Reagent (M-PER; Pierce, Rockford, IL, USA). An equal amount of protein from each cell line was loaded per lane and separated on a 10% sodium dodecyl sulphate (SDS)-Tris glycine polyacrylamide gel electrophoresis (PAGE) gel. Gels were electroblotted onto nitrocellulose membranes (Novex, San Diego, CA, USA) and blocked overnight by incubating with 1 Â Tris-buffered saline containing 0.1% Tween and 5% nonfat dry milk. Membranes were probed with 2 mg/ml antibodies against phosphorylated forms of p38, Akt, ERK, and JNK, and native p38, Akt, ERK, JNK, NF-kBp65, MMP-9, MMP-2, actin, and tubulin (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Bound antibodies were then detected using appropriate peroxidase-coupled secondary antibodies, followed by the use of an enhanced chemiluminescence detection system (ECL, Boehringer Mannheim, Mannheim, Germany).
MMP-9 enzyme-linked immunoabsorbent assays
The supernatant was harvested under sterile conditions, frozen, and stored at -201C. MMP-9 concentration was determined using a commercial ELISA kit (R&D Systems, Abingdon, UK).
Gelatin zymography
The supernatant of HepG2 cells was electrophoresed for the analysis in 9% SDS-PAGE gels containing gelatin (1 mg/ml). The gels were washed for 30 min at room temperature in 2.5% Triton X-100, and were washed several times with ddH 2 O. The gels were incubated in 50 mM Tris (pH 7.6), 1 mM ZnCl 2 , 0.15 M NaCl and 10 mM CaCl 2 for 18 h at 371C. Following incubation, the gels were stained with 0.2% Coomassie blue R250. Bands of lysis representing gelatinase activity were then visualized against a dark background.
MMP-9 gene ablation by As oligodeoxynucleotides
HepG2 cells at 70-80% confluence on 60-mm plastic dishes were transfected with 5 0 -phosphorothioate-modified MMP-9 As oligodeoxynucleotide (ASODN) targeted to bases 1221-1240 of MMP-9 mRNA (GenBank accession no. XM-029934) or missense oligodeoxynucleotide sequences. Oligodeoxynucleotides were diluted in 1 ml of serum-free DMEM (Life Technologies Inc.), mixed, and equilibrated for 20 min with Lipofectamine (Invitrogen Inc., Carlsbad, CA, USA). Final concentration of oligodeoxynucleotides was 20 mM. Cells were treated with the oligodeoxynucleotide mixture for 3 h at 371C. Serum was added to a final concentration of 10%, and the cells were used 48 h later. MMP-9 expression vector was cloned from HepG2 genomic DNA library and cloned into pc-DNA-3 expression vector. 1 Â 10 6 HepG2 cells were transiently transfected with 5 mg MMP-9 expression vector or vehicle pc-DNA-3 by Lipofectamine.
Synthesis of NF-kB and AP-1 decoy ODNs
We used a phosphorothioate double-stranded decoy ODN carrying the NF-kB/Rel-consensus sequence 5 0 -CCTTGAA GGGATTTCCCTCC-3 0 /3 0 -GGAACTT CCCTAAAGGGAG G-5 0 . The AP-1 decoy ODN sequence was 5 0 -TGTCTGACTC ATGTC-3 0 /3 0 -ACA GACTGAGTACAG-5 0 . The mutated (scrambled) form 5 0 -TTGCCGTACCTGACTTAGCC-3 0 /3 0 -AACGGCATGGACTGAATCGG-5 0 was used as a control. ODN (5 mM) was mixed with TransFastt (10:1, v/v) for 15 min at room temperature, and the mixture was added to cells in serum-free medium. After 24 h of transient transfection, the cells were irradiated for the following experiments.
Reporter gene assay A 0.7-kb segment at the 5 0 -flanking region of the human MMP-9 promoter region was amplified by PCR, using specific primers from the human MMP-9 gene (accession no. D10051): 5 0 -ACAATCGAGCTCCTGAAGGAAGAGAGTA AAGC (forward/SacI) and 5 0 -AATCCCAAGCTTATGGT GAGGGCAGAGGTG (reverse/HindIII). The pGL3-Basic vector containing a polyadenylation signal upstream from the luciferase gene was used to construct expression vectors by subcloning PCR-amplified DNA of MMP-9 promoter into the SacI/HindIII site of the pGL3-Basic vector. The PCR products were confirmed on the basis of their size as determined by electrophoresis and DNA sequencing. HepG2 cells (5 Â 10 5 ) were transiently transfected with 5 mg of MMP-9 promoter plasmid using Transfast Transfection Reagent (Promega). This study used cotransfection with pSV-b-galactosidase, conducted data normalization following all transient transfections with triplicate cultures, and repeated every cotransfection protocol three times. The transient-transfected cells were starved of serum for 16 h and were then treated using different protocols as described in the figure legends. Cell lysate luciferase activity was measured using the Luciferase Enzyme Assay System (Promega). For the pNF-kB-Luc promoter activity assay, HepG2 cells were seeded in 12-well plates in triplicate. When reaching about 70% confluence, the cells were transfected with pNF-kB-Luc (BD Bioscience, Clontech, Palo Alto, CA, USA) as described above. After starvation in serumfree medium for 16 h, the cells were irradiated. After another 6 h, the luciferase activities were determined.
Statistical analysis
Statistical evaluation of the data was performed with a twotailed Student's t-test for simple comparison between two values when appropriate. P-values of o0.05 were considered statistically significant.
